PERU, Ill.–(BUSINESS WIRE)–PFS Bancorp, Inc. (the “Company”), the proposed holding company for Peru Federal Savings Bank (the “Bank”), announced today that all final regulatory approvals have been received to complete […]

ATLANTA–(BUSINESS WIRE)–Smith Douglas Homes Corp. (“Smith Douglas”), one of the nation’s fastest growing private homebuilders by number of closings, announced that it has publicly filed a registration statement on Form […]

NEW YORK–(BUSINESS WIRE)–Pixie Dust Technologies, Inc. (NasdaqCM: PXDT) (the “Company”), a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave technology, today announced that it has […]

CELINA, Ohio–(BUSINESS WIRE)–Mercer Bancorp, Inc. (the “Company”), the holding company for Mercer Savings Bank (the “Bank”), announced today that it has completed its initial public offering in connection with the […]

Trading Commences Following Successful Closing of Business Combination with Colombier WEST PALM BEACH, Fla.–(BUSINESS WIRE)–PSQ Holdings, Inc. (NYSE: PSQH) (“PublicSq.” or the “Company”), a leading marketplace of patriotic businesses and […]

NEEDHAM, Mass.–(BUSINESS WIRE)–SharkNinja, Inc. (“SharkNinja”) today announced that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a […]

NEW YORK–(BUSINESS WIRE)–Alpha Healthcare Acquisition Corp. III (Nasdaq: ALPA) (“ALPA”), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding letter of intent […]

BELLEVUE, Wash.–(BUSINESS WIRE)–Savers Value Village, Inc. (“Savers Value Village™”) today announced the launch of its initial public offering of 18,750,000 shares of its common stock. The initial public offering price […]

NEW YORK–(BUSINESS WIRE)–Coliseum Acquisition Corp., a Cayman Islands exempted company, (“Coliseum” or the “Company”) (NASDAQ: MITA) yesterday filed a supplement (the “Proxy Supplement”) to its proxy statement dated June 7, […]

CERo is an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that employ phagocytic mechanisms. Its lead product candidate is expected to enter clinical […]